Primary |
Migraine |
73.6% |
Drug Use For Unknown Indication |
12.7% |
Product Used For Unknown Indication |
5.6% |
Headache |
3.1% |
Cluster Headache |
1.4% |
Migraine Prophylaxis |
0.7% |
Depression |
0.5% |
Pain |
0.4% |
Nausea |
0.2% |
Blood Cholesterol Increased |
0.2% |
Sleep Disorder |
0.2% |
Blood Pressure |
0.2% |
Contraception |
0.2% |
Hypertension |
0.2% |
Addison's Disease |
0.1% |
Anxiety |
0.1% |
Asthma |
0.1% |
Hepatitis C |
0.1% |
Multiple Allergies |
0.1% |
Osteoporosis |
0.1% |
|
Drug Ineffective |
26.8% |
Pharmaceutical Product Complaint |
16.4% |
Product Quality Issue |
9.3% |
Vomiting |
6.3% |
Headache |
4.9% |
Migraine |
4.5% |
Nausea |
4.4% |
Therapeutic Response Decreased |
3.9% |
Somnolence |
2.8% |
Throat Tightness |
2.4% |
Myocardial Infarction |
2.4% |
Drug Administration Error |
2.1% |
Paraesthesia |
2.1% |
Incorrect Route Of Drug Administration |
2.0% |
Overdose |
2.0% |
Wrong Technique In Drug Usage Process |
1.7% |
Pain |
1.6% |
Urticaria |
1.6% |
Chest Pain |
1.5% |
Malaise |
1.5% |
|
Secondary |
Migraine |
50.9% |
Product Used For Unknown Indication |
11.9% |
Drug Use For Unknown Indication |
7.2% |
Headache |
4.0% |
Depression |
2.9% |
Foetal Exposure During Pregnancy |
2.8% |
Hypersensitivity |
2.7% |
Asthma |
2.5% |
Gastrooesophageal Reflux Disease |
1.8% |
Anxiety |
1.7% |
Diabetes Mellitus |
1.6% |
Hypertension |
1.4% |
Pain |
1.4% |
Psoriasis |
1.4% |
Chest Pain |
1.1% |
Muscle Spasms |
1.1% |
Fibromyalgia |
1.0% |
Arthralgia |
0.9% |
Diabetic Neuropathy |
0.9% |
Fluid Retention |
0.8% |
|
Drug Ineffective |
20.4% |
Pharmaceutical Product Complaint |
11.6% |
Vomiting |
11.2% |
Drug Hypersensitivity |
8.4% |
Product Quality Issue |
7.3% |
Migraine |
6.6% |
Therapeutic Response Decreased |
4.8% |
Somnolence |
4.0% |
Myocardial Infarction |
3.3% |
Headache |
2.9% |
Memory Impairment |
2.9% |
Nausea |
2.9% |
Tremor |
2.2% |
Injection Site Pain |
1.8% |
Overdose |
1.8% |
Urticaria |
1.8% |
Visual Disturbance |
1.8% |
Weight Increased |
1.8% |
Palpitations |
1.5% |
Hypersensitivity |
1.3% |
|
Concomitant |
Migraine |
20.1% |
Product Used For Unknown Indication |
17.1% |
Drug Use For Unknown Indication |
8.1% |
Pain |
7.1% |
Depression |
5.9% |
Headache |
4.8% |
Contraception |
4.8% |
Anxiety |
3.4% |
Asthma |
3.1% |
Gastrooesophageal Reflux Disease |
3.1% |
Multiple Sclerosis |
3.0% |
Hypertension |
2.7% |
Rheumatoid Arthritis |
2.6% |
Premenstrual Syndrome |
2.5% |
Crohn's Disease |
2.2% |
Insomnia |
2.2% |
Acne |
2.1% |
Nausea |
1.8% |
Bipolar Disorder |
1.8% |
Sleep Disorder |
1.7% |
|
Vomiting |
12.5% |
Pulmonary Embolism |
9.9% |
Weight Increased |
8.0% |
Weight Decreased |
6.7% |
Migraine |
6.2% |
Pain |
6.2% |
Nausea |
6.1% |
Deep Vein Thrombosis |
4.6% |
Drug Ineffective |
4.5% |
Headache |
4.4% |
Anxiety |
3.7% |
Vision Blurred |
3.7% |
Pharmaceutical Product Complaint |
3.6% |
Wrong Technique In Drug Usage Process |
3.6% |
Pain In Extremity |
3.1% |
Suicidal Ideation |
3.0% |
Thrombosis |
2.9% |
Type 2 Diabetes Mellitus |
2.7% |
Injury |
2.3% |
Somnolence |
2.3% |
|
Interacting |
Depression |
20.0% |
Migraine |
16.0% |
Pain |
16.0% |
Rheumatoid Arthritis |
16.0% |
Blood Cholesterol Abnormal |
8.0% |
Sjogren's Syndrome |
8.0% |
Sleep Disorder |
8.0% |
Anxiety |
4.0% |
Panic Disorder |
4.0% |
|
Feeling Abnormal |
25.0% |
Foot Fracture |
25.0% |
Migraine |
25.0% |
Therapeutic Response Unexpected |
25.0% |
|